CRESCENT BIOPHARMA, INC.

financial.report · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.
Event type
financial.report
Occurred
2025-09-30
Reported
2025-11-06
Disclosure lag
37 days

Context

links are based on the recorded entity type
FieldRecorded value
EntityCRESCENT BIOPHARMA, INC.
SourceSEC EDGAR
Source identifiercompanyfacts/CIK0001253689/2026-07-26
Event ID#27527

Recorded payload

JSON payload as stored after parsing
{
  "accession": "0001628280-25-049868",
  "canonical_covered": 11,
  "canonical_total": 12,
  "fiscal_period": "Q3",
  "fiscal_year": 2025,
  "form": "10-Q",
  "mapped_tag_share": 0.05128205128205128,
  "metrics": {
    "cash_and_equivalents": 133265000,
    "net_income": -24607000,
    "operating_income": -25885000,
    "shareholders_equity": 116641000,
    "shares_outstanding": 13892516,
    "total_assets": 138269000,
    "total_liabilities": 21628000
  },
  "metrics_reported": 7,
  "period_end": "2025-09-30"
}

Source: SEC EDGAR · as of 2025-11-06T00:00:00Z

CRESCENT BIOPHARMA, INC. — recorded event — Tapewire